Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Nashville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Nashville, TN

Studies commonly pay $75 to $4,500 per completed study

1,342 clinical trials are currently recruiting participants within 30 miles of Nashville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,342studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Nashville right now

Top 25 of 1,342 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
The Children's Hospital at TriStar Centennial — Nashville, Tennessee (0.4 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Locally Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 30 participants sought
Sarah Cannon Research Institute (SCRI) Oncology Partners — Nashville, Tennessee (0.4 mi) · Sponsor: Acepodia Biotech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06415487)

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 120 participants sought
Sarah Cannon Research Institute (SCRI) Oncology Partners — Nashville, Tennessee (0.4 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06465329)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
SCRI Oncology Partners ( Site 7002) — Nashville, Tennessee (0.4 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Tennessee Oncology, PLLC — Nashville, Tennessee (0.4 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Relapsed/Refractory Multiple Myeloma Phase 2 Interventional 100 participants sought
Tennessee Oncology — Nashville, Tennessee (0.4 mi) · Sponsor: C4 Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284758)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Tennessee Retina — Nashville, Tennessee (0.4 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Tennessee Retina PC — Nashville, Tennessee (0.4 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Text-messaging Intervention to Support Parents After Their Child's Psychiatric Emergency

Parents, Self Efficacy N/A Interventional 90 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi) · Sponsor: Vanderbilt University Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06456762)

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Solid Tumor, Adult, Metastatic Breast Cancer Phase 1 Interventional 392 participants sought
SCRI Oncology Partners — Nashville, Tennessee (0.4 mi) · Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See eligibility & contact on ClinicalTrials.gov (NCT06625775)

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine Phase 3 Interventional 420 participants sought
Access Clinical Trials Inc /ID# 270280 — Nashville, Tennessee (0.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06810505)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Nashville, Tennessee (0.4 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Nashville, Tennessee (0.4 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee (0.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Acute Myeloid Leukemia (AML) Phase 3 Interventional 1,300 participants sought
Tennessee Oncology — Nashville, Tennessee (0.4 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07007312)

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Advanced Breast Cancer Phase 2 Interventional 24 participants sought
Research Site — Nashville, Tennessee (0.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07427394)

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Breast Cancer Phase 2 Interventional 36 participants sought
SCRI Oncology Partners — Nashville, Tennessee (0.4 mi) · Sponsor: SCRI Development Innovations, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05748834)

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Ventricular Tachycardia (VT) N/A Interventional 60 participants sought
Vanderbilt University Medical Center — Nashville, Tennessee (0.4 mi) · Sponsor: Medtronic Cardiac Ablation Solutions
See eligibility & contact on ClinicalTrials.gov (NCT06703489)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
TriStar Centennial Medical Center — Nashville, Tennessee (0.4 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Sarah Cannon Research Institute — Nashville, Tennessee (0.4 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)
Actively enrolling

Studies you may be able to join near Nashville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Nashville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Vanderbilt Clinical Research Center

★ 5.0
1161 21st Ave S Suite 2400, Nashville, TN 37232
(615) 322-2312

Clinical Research Associates Inc

★ 4.7
1500 Church St, Nashville, TN 37203
(615) 329-0197
"Incredible staff! Efficient, friendly, helpful…. I’ve had so much fun! Apply to be a participant today!"
— Curtis B, 5★

Tennessee Clinical Research

★ 3.8
2000 Richard Jones Rd #223, Nashville, TN 37215
(615) 383-9660
"I have nothing to compare to ,I have not tried anything for my hair loss as of yet.It was easy filling out the questions and ,when and if I get to pa…"
— Sajadia Gonzalez, 3★

Greco-Hainsworth Centers for Research - DDU

322 22nd Ave N Ste 300, Nashville, TN 37203
(615) 460-3825

Sarah Cannon Research Institute

★ 4.4 (26 reviews)
250 25th Ave N, Nashville, TN 37203
(615) 329-7274
"The oncologist is first rate. The facility/staffing is not. One would think that a facility dedicated to treatment for people with compromised immune…"
— J H, 3★

SCRI Oncology Partners

★ 4.9 (262 reviews)
335 24th Ave N #200, Nashville, TN 37203
(615) 329-7640
"I do not recommend going here. I started with this oncology practice after being diagnosed with breast cancer. What I don't like is their appointment…"
— dageminii05 Gogirl, 2★

Medical Research Building III

★ 5.0
465 21st Ave S, Nashville, TN 37232

TriStar Centennial Medical Center

★ 4.6
2300 Patterson St, Nashville, TN 37203
(615) 342-1000

Preston Cancer Research Building Vanderbilt University Medical Center

★ 5.0
2220 Pierce Ave, Nashville, TN 37232
(615) 936-8422
"Amazing service! It’s not exactly where I want to be, but they do an excellent job of being hospitable."
— TRACIE ROBINSON, 5★

Clinical trials in Nashville: what's recruiting

The Nashville area currently has 1,342 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Nashville, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Nashville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Nashville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Nashville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Nashville?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Nashville, TN?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Nashville?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Nashville?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Nashville.

Paid clinical trials near Nashville

Other metros within reach

Murfreesboro, TN77 Clarksville, TN8 Huntsville, AL92 Chattanooga, TN146 Evansville, IN66 Louisville, KY566 Birmingham, AL966 Knoxville, TN231

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Nashville Bladder Issues Due To Spinal Cord Injury in Nashville All conditions

More of TN

Memphis580 Knoxville231 Chattanooga146 Murfreesboro77 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts